EUVIMEDEUVIMED entdecken
Open Access

Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer

Huaqiu Chen, Huanyu Xie, Yuanyuan Zhang, Guangming Wang

Cancer Biomarkers · 2023

DOI: 10.3233/cbm-220347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2023. Verfasst von Huaqiu Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Dali University, Dali, Yunnan, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cervical cancer (CC) is a malignant tumor threatening women’s health. Replication factor C (RFC) 5 is significantly highly expressed in CC tissues, and the immune microenvironment plays a crucial role in tumor initiation, progression, and metastasis. OBJECTIVE: To determine the prognostic role of RFC5 in CC, analyze the immune genes significantly associated with RFC5, and establish a nomogram to evaluate the prognosis of patients with CC. METHODS: High RFC5 expression in patients with CC was analyzed and verified through TCGA GEO, TIMER2.0, and HPA databases. A risk score model was constructed using RFC5-related immune genes identified using R packages. Combining the risk score model and clinical information of patients with CC, a nomogram was constructed to evaluate the prognosis of patients with CC. RESULTS: Comprehensive analysis showed that the risk score was a prognostic factor for CC. The nomogram could predict the 3-year overall survival of patients with CC. CONCLUSIONS: RFC5 was validated as a biomarker for CC. The RFC5 related immune genes were used to establish a new prognostic model of CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsHumansFemalePrognosisNomogramsCell Transformation, NeoplasticDatabases, FactualTumor MicroenvironmentReplication Protein C

Stichwörter der Autor:innen

Cervical cancerimmunoinhibitorsimmunostimulatorsprognostic signaturerisk score

Substanzen

RFC5 protein, humanReplication Protein C

Autor:innen und Institutionen

  • School of Clinical Medicine, Dali University, Dali, Yunnan, China.
  • Xichang People's Hospital, Xichang, Sichuan, China.
  • Affiliated Hospital of Xichang College, Xichang, Sichuan, China.

Zitieren

APA

Chen, H., Xie, H., Zhang, Y., & Wang, G. (2023). Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer. Cancer Biomarkers. https://doi.org/10.3233/cbm-220347

Vancouver

Chen H, Xie H, Zhang Y, Wang G. Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer. Cancer Biomarkers. 2023. doi:10.3233/cbm-220347

BibTeX
@article{Chen2023,
  author = {Chen, Huaqiu and Xie, Huanyu and Zhang, Yuanyuan and Wang, Guangming},
  title = {Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer},
  journal = {Cancer Biomarkers},
  year = {2023},
  doi = {10.3233/cbm-220347}
}
Kostenlos starten →